Neurobiology of obsessive-compulsive disorder - Part 1: Pathophysiological and genetic concepts;Neurobiologie der zwangsstörung - Teil 1: Konzepte zur pathophysiologie und genetik

Nervenheilkunde

Volumn 28, Issue 9, 2009, Pages 625-630

  Zurowski, Bartosz ^a   Hohagen, F ^a   Kordon, A ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Basal ganglion; OCD; Orbitofrontal cortex; Tourette syndrome

Indexed keywords

NEUROTRANSMITTER;

BASAL GANGLION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GILLES DE LA TOURETTE SYNDROME; HEREDITY; HUMAN; NEUROBIOLOGY; NEUROIMAGING; NEUROLOGIC DISEASE; NEUROPHYSIOLOGY; OBSESSIVE COMPULSIVE DISORDER; PATHOPHYSIOLOGY; PHENOTYPE; REVIEW;

EID: 69549131012     PISSN: 07221541     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1628687     Document Type: Review

References (43)

1. Alexander GE, Crutcher MD, DeLong MR. Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and limbic functions. Prog Brain Res 1990; 85: 119-146
2. Arnold PD, Sicard T, Burroughs E, Richter MA, Kennedy JL. Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder. Arch Gen Psychiatry 2006; 63: 769-776
3. Baxter LR et al. Brain Mediation of Obsessive-Compulsive Disorder Symptoms: Evidence From Functional Brain Imaging Studies in the Human and Nonhuman Primate. Semin Clin Neuropsychiatry 1996; 1: 32-47.
4. Bloch MH, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken MB, Leckman JF. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry 2006; 11: 622-632 (Pubitemid 43989810)
5. Canales JJ, Graybiel AM. A measure of striatal function predicts motor stereotypy. Nat Neurosci 2000; 3: 377-383
6. Chamberlain SR et al. Orbitofrontal dysfunction in patients with obsessive-compulsive disorder and their unaffected relatives. Science 2008; 321: 421-422
7. Clarke HF, Robbins TW, Roberts AC. Lesions of the medial striatum in monkeys produce perseverative impairments during reversal learning similar to those produced by lesions of the orbitofrontal cortex. J Neurosci 2008; 28: 10972-10982
8. den Braber A et al. An fMRI study in monozygotic twins discordant for obsessive-compulsive symptoms. Biol Psychol 2008; 79: 91-102.
9. el Mansari M, Bouchard C, Blier P. Alteration of serotonin release in the guinea pig orbito-frontal cortex by selective serotonin reuptake inhibitors. Relevance to treatment of obsessive-compulsive disorder. Neuropsychopharmacology 1995; 13: 117-127
10. Feygin DL, Swain JE, Leckman JF. The normalcy of neurosis: evolutionary origins of obsessive-compulsive disorder and related behaviors. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30: 854-864
11. Fullana MA et al. Personality characteristics in obsessive- compulsive disorder and individuals with subclinical obsessive-compulsive problems. Br J Clin Psychol 2004; 43: 387-398
12. Hanna GL, Himle JA, Curtis GC, Gillespie BW. A family study of obsessive-compulsive disorder with pediatric probands. Am J Med Genet B Neuropsychiatr Genet 2005; 134: 13-19 (Pubitemid 40411102)
13. Hettema JM, Neale MC, Kendler KS. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 2001; 158: 1568-1578 (Pubitemid 32923644)
14. Kluge M, Schussler P, Kunzel HE, Dresler M, Yassouridis A, Steiger A. Increased nocturnal secretion of ACTH and cortisol in obsessive compulsive disorder. J Psychiatr Res 2007; 41: 928-933 (Pubitemid 47259089)
15. Kordon A et al. Quetiapine addition to serotonin reuptake inhibitors in patients with severe obsessive- compulsive disorder: a double-blind, randomized, placebo-controlled study. J Clin Psychopharmacol 2008; 28: 550-554
16. Kordon A, Zurowski B, Hohagen F. Zwangsstörungen. In: Holsboer F, Gründer G, Benkert O (Hrsg). Handbuch der Psychopharmakotherapie. Berlin: Springer 2008.
17. Kulkarni J et al. Estrogen in severe mental illness: a potential new treatment approach. Arch Gen Psychiatry 2008; 65: 955-960
18. Leckman JF, Mayes LC, Feldman R, Evans DW, King RA, Cohen DJ. Early parental preoccupations and behaviors and their possible relationship to the symptoms of obsessive-compulsive disorder. Acta Psychiatr Scand Suppl 1999; 396: 1-26. (Pubitemid 29374413)
19. Liang KY et al. Evidence for potential relationship between SLC1A1 and a putative genetic linkage region on chromosome 14q to obsessive-compulsive disorder with compulsive hoarding. Am J Med Genet B Neuropsychiatr Genet 2008; 147B: 1000-1002
20. Maia AS, Barbosa ER, Menezes PR, Miguel Filho EC. Relationship between obsessive-compulsive disorders and diseases affecting primarily the basal ganglia. Rev Hosp Clin Fac Med Sao Paulo 1999; 54: 213-221
21. Maina G, Albert U, Bogetto F, Vaschetto P, Ravizza L. Recent life events and obsessive-compulsive disorder (OCD): the role of pregnancy/delivery. Psychiatry Res 1999; 89: 49-58.
22. Mataix-Cols D, Rosario-Campos MC, Leckman JF. A multidimensional model of obsessive-compulsive disorder. Am J Psychiatry 2005; 162: 228-238
23. Menzies L et al. Neurocognitive endophenotypes of obsessive-compulsive disorder. Brain 2007; 130: 3223-3236
24. Miguel EC et al. Obsessive-compulsive disorder phenotypes: implications for genetic studies. Mol Psychiatry 2005; 10: 258-275 (Pubitemid 40432680)
25. Moresco RM et al. Fluvoxamine treatment and D2 receptors: a pet study on OCD drug-naive patients. Neuropsychopharmacology 2007; 32: 197-205. (Pubitemid 44967798)
26. Nestadt G et al. A family study of obsessive-compulsive disorder. Arch Gen Psychiatry 2000; 57: 358-363
27. Nordstrom EJ, Burton FH. A transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder circuitry. Mol Psychiatry 2002; 7: 617-625
28. Ogai M, Iyo M, Mori N, Takei N. A right orbitofrontal region and OCD symptoms: a case report. Acta Psychiatr Scand 2005; 111: 74-76
29. Pauls DL, Alsobrook JP, 2nd, Goodman W, Rasmussen S, Leckman JF. A family study of obsessivecompulsive disorder. Am J Psychiatry 1995; 152: 76-84.
30. Pittenger C, Krystal JH, Coric V. Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder. NeuroRx 2006; 3: 69-81. (Pubitemid 43276634)
31. Rosenberg DR, MacMillan S. Imaging and neurocircuitry of OCD. In: Davis KL, Charney D, Coyle JT, Nemeroff C, editors. Neuropsychopharmacology: The fifth generation of progress: American College of Neuropsychopharmacology 2002; 1621-1645
32. Schwartz J. Brain lock: Free yourself from obsessivecompulsive disorder. New York: Regan Books/ Harper Collins 1996.
33. Shugart YY, Wang Y, Samuels JF, Grados MA, Greenberg BD, Knowles JA, et al. A family-based association study of the glutamate transporter gene SLC1A1 in obsessive-compulsive disorder in 378 families. Am J Med Genet B Neuropsychiatr Genet 2009, im Druck.
34. Stewart SE et al. Association of the SLC1A1 glutamate transporter gene and obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet 2007; 144B: 1027-1033 (Pubitemid 350207777)
35. Thobois S, Jouanneau E, Bouvard M, Sindou M. Obsessive-compulsive disorder after unilateral caudate nucleus bleeding. Acta Neurochir (Wien) 2004; 146: 1027-1031 (Pubitemid 39222800)
36. Tolin DF, Frost RO, Steketee G. An open trial of cognitive- behavioral therapy for compulsive hoarding. Behav Res Ther 2007; 45: 1461-1470 (Pubitemid 46669446)
37. Veenstra-VanderWeele J, Kim SJ, Gonen D, Hanna GL, Leventhal BL, Cook EH, Jr. Genomic organization of the SLC1A1/EAAC1 gene and mutation screening in early-onset obsessive-compulsive disorder. Mol Psychiatry 2001; 6: 160-167
38. Wendland JK et al. A haplotype containing quantitative trait loci for SLC1A1 gene expression and its association with obsessive-compulsive disorder. Arch Gen Psychiatry 2009; 66: 408-416
39. Westenberg HG, Fineberg NA, Denys D. Neurobiology of obsessive-compulsive disorder: serotonin and beyond. CNS Spectr 2007; 12: 14-27.
40. Williams KE, Koran LM. Obsessive-compulsive disorder in pregnancy, the puerperium, and the premenstruum. J Clin Psychiatry 1997; 58: 330-334 (Pubitemid 27362495)
41. Zurowski B, Wahl K, Hohagen F, Kordon A. Symptom remission in OCD after discontinuation of pharmacotherapy with fluoxetine: a case for looking beyond serotonin. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 959-960 (Pubitemid 46661966)
42. Zurowski B, Kordon A, Wahl K, Hohagen F. Non-selective effects of selective serotonin reuptake inhibitors. Biol Psychiatry 2008; 63: e5. (Pubitemid 350234893)
43. Zurowski B, Hohagen F, Kordon A. Neurobiologie der Zwangsstörung. Teil 2: Konzepte und Befunde aus der Neurobildgebung. Nervenheilkunde 2009; 28; in Druck.